Non-Vitamin K Antagonist Oral Anticoagulants and Risk of Myocardial Infarction in Patients with Atrial Fibrillation with or without Percutaneous Coronary Interventions: A Meta-Analysis

The study aimed to assess the risk of myocardial infarction (MI) and major adverse cardiac events during non-vitamin K antagonist oral anticoagulants (NOAC) compared to warfarin therapy in patients with atrial fibrillation (AF), both treated and not treated with percutaneous coronary interventions (...

Descripción completa

Detalles Bibliográficos
Autores principales: Grajek, Stefan, Kałużna-Oleksy, Marta, Siller-Matula, Jolanta M., Grajek, Maksymilian, Michalak, Michał
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539187/
https://www.ncbi.nlm.nih.gov/pubmed/34683155
http://dx.doi.org/10.3390/jpm11101013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8539187/
https://www.ncbi.nlm.nih.gov/pubmed/34683155
http://dx.doi.org/10.3390/jpm11101013

Ejemplares similares